Ironwood Pharmaceuticals (IRWD) EPS (Diluted) Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 26.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.90% |
| Mar 31, 2026 | -0.04% |
| Dec 31, 2025 | -51.49% |
| Sep 30, 2025 | -6.15% |
| Jun 30, 2025 | -12.70% |
| Mar 31, 2025 | -46.35% |
| Dec 31, 2024 | 56.62% |
| Sep 30, 2024 | -59.23% |
| Jun 30, 2024 | -26.04% |
| Mar 31, 2024 | -28.19% |
| Dec 31, 2023 | -74.36% |
| Jun 30, 2023 | -26.92% |
| Mar 31, 2023 | -77.29% |
| Mar 31, 2022 | 26.01% |
| Dec 31, 2021 | 53.40% |
| Sep 30, 2021 | 56.21% |
| Jun 30, 2021 | 137.81% |
| Mar 31, 2021 | 55.94% |
| Dec 31, 2020 | -27.55% |
| Jun 30, 2020 | 628.14% |